Jamil H, Chu C H, Dickson J K, Chen Y, Yan M, Biller S A, Gregg R E, Wetterau J R, Gordon D A
Department of Metabolic Diseases, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA.
J Lipid Res. 1998 Jul;39(7):1448-54.
The microsomal triglyceride transfer protein (MTP) is a heterodimeric lipid transfer protein that is required for the assembly and secretion of apolipoprotein B (apoB)-containing lipoproteins. A key unresolved question is whether the MTP-mediated step is rate limiting. To address this, a unique experimental strategy was used that allowed the in situ modulation and measurement of MTP triglyceride transfer activity. In order to accomplish this, an irreversible photoaffinity inhibitor, BMS-192951, was designed and synthesized. When incubated with purified MTP and irradiated with UV light at 360 nm, BMS-192951 inhibits triglyceride transfer by covalently binding to the protein. HepG2 cells were treated with either increasing concentrations of BMS-192951 (0-15 microM) with 5 min of ultraviolet irradiation, or 3.0 microM BMS-192951 with various lengths (0-15 min) of ultraviolet irradiation. Microsomal extracts were prepared exhaustively dialyzed to remove unbound inhibitor, and assayed for MTP-mediated triglyceride transfer activity. BMS-192951 was shown to reduce MTP activity in both a dose- and UV exposure time-dependent fashion. Measurement of apoB concentration in the media showed that apoB secretion was reduced in proportion to the in situ inhibition of MTP activity, while no change was observed in apoA-I secretion. Experiments performed in McArdle RH-7777 rat hepatoma cells and primary rat hepatocytes gave nearly identical results; the decrease in apoB secretion was proportional to the decrease in MTP activity. These results indicate that MTP-mediated lipid transfer is limiting in the assembly and secretion of apoB-containing lipoproteins in hepatic cells under the conditions tested.
微粒体甘油三酯转运蛋白(MTP)是一种异二聚体脂质转运蛋白,它是含载脂蛋白B(apoB)的脂蛋白组装和分泌所必需的。一个关键的未解决问题是MTP介导的步骤是否是限速步骤。为了解决这个问题,采用了一种独特的实验策略,该策略允许对MTP甘油三酯转运活性进行原位调节和测量。为了实现这一点,设计并合成了一种不可逆的光亲和抑制剂BMS-192951。当与纯化的MTP一起孵育并用360nm的紫外光照射时,BMS-192951通过与蛋白质共价结合来抑制甘油三酯转运。用递增浓度的BMS-192951(0-15 microM)处理HepG2细胞并进行5分钟的紫外线照射,或用3.0 microM BMS-192951进行不同时长(0-15分钟)的紫外线照射。制备微粒体提取物并进行充分透析以去除未结合的抑制剂,然后测定MTP介导的甘油三酯转运活性。结果表明,BMS-192951以剂量和紫外线暴露时间依赖性方式降低MTP活性。培养基中apoB浓度的测量表明,apoB分泌与MTP活性的原位抑制成比例降低,而apoA-I分泌未观察到变化。在McArdle RH-7777大鼠肝癌细胞和原代大鼠肝细胞中进行的实验给出了几乎相同的结果;apoB分泌的减少与MTP活性的降低成比例。这些结果表明,在所测试的条件下,MTP介导的脂质转运在肝细胞中含apoB脂蛋白的组装和分泌过程中是限速的。